Biofourmis Healthcare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Oncology, Rare/Orphan Diseases and
Gene Therapy
SINGAPORE, April 15, 2021 /PRNewswire/ Juniper Biologics, a science-led healthcare company focused on researching, developing & commercialising novel therapies, has announced the appointment of celebrated pharmaceutical executive Raman Singh to the role of Chief Executive.
Juniper Biologics will be focused on researching, developing and commercialising innovative medications in the areas of Oncology, Rare/Orphan Diseases and Gene Therapy. The company is headquartered in Singapore.
Juniper Biologics was founded on a vision to provide the next generation of life-changing treatments for unmet needs focused on specialist therapy areas in which it can make the most difference. The company has the goal of bringing in cutting edge innovation and improving the quality of life of the human race and especially in the wake of the COVID-19 pande ....

United States , New Zealand , South Korea , Raman Singh , Capital Group , Economic Development Board , Juniper Biologics , Orphan Diseases , Consumer Business , General Manager , Singapore Tourism Board , Most Powerful People , Medicine Maker , Excellence Awards , Biofourmis Healthcare , Gene Therapy , Middle East , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , தெற்கு கொரியா , ராமன் சிங் , மூலதனம் குழு , பொருளாதார வளர்ச்சி பலகை , ஆர்ஃபந் நோய்கள் , நுகர்வோர் வணிக , ஜநரல் மேலாளர் ,